Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CinCor Pharma
Biotech
AstraZeneca gears up for baxdrostat FDA filing after ph. 3 win
AstraZeneca’s hypertension pill baxdrostat lowered blood pressure by almost 10 mmHg, the Big Pharma has revealed as it gears up to seek approval.
James Waldron
Sep 1, 2025 6:13am
AstraZeneca’s $1.3B hypertension med bet pays off with ph. 3 win
Jul 14, 2025 4:09am
Oncorus C-suite out the door—Chutes & Ladders
Jun 9, 2023 9:30am
Amarin CEO abruptly resigns—Chutes & Ladders
Apr 7, 2023 9:30am
AstraZeneca eagerness for CinCor revealed in larger first offer
Jan 24, 2023 11:36am
AstraZeneca inks $1.8B CinCor takeover for blood pressure drug
Jan 9, 2023 7:20am
